Sars‐CoV ‐2 infection in India bucks the trend

Trained innate immunity

Datos Bibliográficos

ID19458955
AutoresSreedhar Chinnaswamy (0000-0003-0095-3453, Infectious Disease Genetics National Institute of Biomedical Genomics Kalyani India, autor de correspondencia)
Año2021
Volumen33
Número6
Páginase23504-e23504
Fecha de publicación2021-11-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaAmerican Journal of Human Biology (JOURNAL)
Identificadores de la revistaISSN: 1042-0533 • E-ISSN: 1520-6300
EditorialWiley (PUBLISHER • GB)
DOI10.1002/ajhb.23504
PMID32965717
OpenAlexW3087541171
IdiomaEN
Citas recibidas5
Referencias citadas134

SARS‐CoV‐2, the causative agent of COVID‐19 pandemic caught the world unawares by its sudden onset in early 2020. Memories of the 1918 Spanish Flu were rekindled raising extreme fear for the virus, but in essence, it was the host and not the virus, which was deciding the outcome of the infection. Age, gender, and preexisting conditions played critical roles in shaping COVID‐19 outcome. People of lower socioeconomic strata were disproportionately affected in industrialized countries such as the United States. India, a developing country with more than 1.3 billion population, a large proportion of it being underprivileged and with substandard public health provider infrastructure, feared for the worst outcome given the sheer size and density of its population. Six months into the pandemic, a comparison of COVID‐19 morbidity and mortality data between India, the United States, and several European countries, reveal interesting trends. While most developed countries show curves expected for a fast‐spreading respiratory virus, India seems to have a slower trajectory. As a consequence, India may have gained on two fronts: the spread of the infection is unusually prolonged, thus leading to a curve that is “naturally flattened”; concomitantly the mortality rate, which is a reflection of the severity of the disease has been relatively low. I hypothesize that trained innate immunity, a new concept in immunology, may be the phenomenon behind this. Biocultural, socioecological, and socioeconomic determinants seem to be influencing the outcome of COVID‐19 in different regions/countries of the world

Developing country · Disease · Economic growth · Economics · Environmental health · Immune system · Immunity · Pandemic · Population · Socioeconomic status · Sociology · COVID-19 epidemiological studies · Demography · Immune responses and vaccinations · Medicine · SARS-CoV-2 and COVID-19 Research · Immunology · Internal Medicine